![Alan K. Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan K. Smith
Directeur/Membre du Conseil chez
CHATA Biosystems, Inc.
Profil
Alan K.
Smith is currently a Director at CHATA Biosystems, Inc. and a Director at Armis Biopharma, Inc. He previously held positions such as President & Chief Executive Officer at Cognate BioServices, Inc., Vice President-Research at Vericel Corp., and COO, SVP-Research & Development at Osiris Therapeutics, Inc. He was also President & Chief Operating Officer at Theradigm, Inc. and Executive Vice President-Technical Operations at Bellicum Pharmaceuticals, Inc. Additionally, he was Vice President-Cellular Therapeutics, R&D at LifeNet Health, Inc. and Chief Technology Officer at Akouos, Inc. Dr. Smith received his undergraduate degree from Southern Utah University and his doctorate from Utah State University in 1983.
Postes actifs de Alan K. Smith
| Sociétés | Poste | Début |
|---|---|---|
CHATA Biosystems, Inc.
 CHATA Biosystems, Inc. Wholesale DistributorsDistribution Services Manufactures pre packaged chemical solutions | Directeur/Membre du Conseil | - |
Armis Biopharma, Inc.
 Armis Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharma products for the treatment and prevention of drug-resistant infections | Directeur/Membre du Conseil | 01/01/1998 |
Anciens postes connus de Alan K. Smith
| Sociétés | Poste | Fin |
|---|---|---|
| AKOUOS | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| BELLICUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 24/06/2020 |
LifeNet Health, Inc.
 LifeNet Health, Inc. BiotechnologyHealth Technology Develops regenerative medicine and translational research & proprietary bio-preservation technologies | Corporate Officer/Principal | 01/10/2015 |
Theradigm, Inc.
 Theradigm, Inc. Medical/Nursing ServicesHealth Services Develops stem-cell-based therapies to treat diseases of the central nervous system | President | 30/07/2010 |
| OSIRIS THERAPEUTICS, INC. | Directeur des opérations | 01/01/2002 |
Formation de Alan K. Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
CHATA Biosystems, Inc.
CHATA Biosystems, Inc. Wholesale DistributorsDistribution Services Manufactures pre packaged chemical solutions | Distribution Services |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Southern Utah University
 Southern Utah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah State University
 Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeNet Health, Inc.
LifeNet Health, Inc. BiotechnologyHealth Technology Develops regenerative medicine and translational research & proprietary bio-preservation technologies | Health Technology |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Health Technology |
Theradigm, Inc.
Theradigm, Inc. Medical/Nursing ServicesHealth Services Develops stem-cell-based therapies to treat diseases of the central nervous system | Health Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Armis Biopharma, Inc.
Armis Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharma products for the treatment and prevention of drug-resistant infections | Health Technology |
Choisissez Zonebourse 
